Brief: Bioservo Posts Q4 Adj. Loss Per Share of SEK 0.56

Bioservo Technologies AB

22/02/2023 07:35

Feb 22 (Reuters) - Bioservo Q4 EBITDA SEK -15.5 million.
* Q4 adjusted free cash flow SEK -13.5 million
* Q4 sales SEK 1.3 million
* Q4 EBIT SEK -16 million